Professor Tobias Arkenau is a highly-respected Consultant Medical Oncologist who works at several HCA Healthcare locations, including Sarah Cannon Research Institute, The Harley Street Clinic, The Princess Grace and The Wellington Hospital. He also has an NHS post at University College London Hospital where he is a Professorial Research Associate.

He was awarded his medical degree from Hanover Medical School in Germany in 2000. After this, he completed specialist training in oncology across several centres of excellence including the Royal Marsden Hospital. He was given a Fellowship by the Royal College of Physicians, and is highly regarded for his research contributions to his field of Gastrointestinal Cancers, Drug Development and Immunotherapy.

Professor Arkenau is one of the founding Medical Directors of the Sarah Cannon Research Institute UK and is currently serving as Executive Medical Director for SCRI UK. He also has the role of Clinical Lead for the HCA Healthcare UK Cancer Service Line. This highly skilled physician has a wide range of experience in many different types of cancers, primarily gastrointestinal and skin cancers.

He has published countless peer-reviewed articles and book chapters over the course of his career, and regularly presents at international conferences such as ASCO, ESMO and AACR. He currently leads the Sarah Cannon Institute UK as Chief Investigator for a number of clinical trials involving new anti-cancer treatments like immunotherapy and cellular therapy.

Diseases, Medical Tests and Treatments

• Immunotherapy
• Chemotherapy
• Clinical Trials, Phase-1 studies
• Drug Development, Experimental Therapies
• TIL-Therapy
• Biological Therapy
• Video Consultation
• Genetic Testing (Genomics Review Board)
• Gastrointestinal Cancer
• Skin Cancer
• Upper Gastrointestinal Cancer
• Lower Gastrointestinal Cancer
• Melanoma
• Bile Duct Cancer
• Bowel Cancer
• Colon Cancer
• Gallbladder Cancer
• Liver Cancer
• Oesophagus Cancer
• Pancreatic Cancer
• Stomach Cancer
• Small Bowel Cancer